drugset / Trial / NCT02510274
Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to assess PK, safety and tolerability of a single oral dose of ASP3325 and to assess PD, PK and safety of repeated oral doses of ASP3325 administered t.i.d. before or just after each meal
Timeline
- Start
- 2014-05-12
- Primary completion
- 2014-11-04
- Completion
- 2014-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP3325 | Unknown | — | Oral |